10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Diltiazem Hydrochloride Extended-Release Tablets in dosage form, from India
Issued February 1, 2019 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN3 N302362 (February 1, 2019)
Tariff classification
HTS codes: 3004.90.9220
Headings: 3004
Product description
Diltiazem Hydrochloride is a medicinal preparation in extended-release capsule form indicated for the treatment of hypertension. It will be imported in dosages of 120 mg, 180 mg, 240 mg, 300 mg, 360 mg and 420 mg capsules.
CBP rationale
The applicable subheading for the Diltiazem Extended-Release Tablets in dosage form will be 3004.90.9220, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments.
Full text
N302362 February 1, 2019 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9220 Mr. Pradeep Shah Zydus Pharmaceuticals USA Inc. 73 Route 31 North Pennington, NJ 08534 RE: The tariff classification of Diltiazem Hydrochloride Extended-Release Tablets in dosage form, from India Dear Mr. Shah: In your letter dated December 17, 2018, you requested a tariff classification ruling. Diltiazem Hydrochloride is a medicinal preparation in extended-release capsule form indicated for the treatment of hypertension. It will be imported in dosages of 120 mg, 180 mg, 240 mg, 300 mg, 360 mg and 420 mg capsules. The applicable subheading for the Diltiazem Extended-Release Tablets in dosage form will be 3004.90.9220, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments." The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Clonidine Hydrochloride Extended-Release Tablets in dosage form, from India
The tariff classification of Enoxaparin Sodium Injection in dosage form, from China
The tariff classification of Enoxaparin Sodium Injection in dosage form, from China
The tariff classification of Metoprolol Succinate Extended Release Tablets in dosage form, from India
The tariff classification of Scopolamine Transdermal System from Australia and Pitavastatin Tablets from India
The tariff classification of Labetalol Hydrochloride Injection in dosage form, from Italy
The tariff classification of Icosapent Ethyl Capsules in dosage form, from China, and the classification of Norelgestromin and Ethinyl Estradiol Transdermal System from Argentina and India
The tariff classification of Dofetilide Capsules in dosage form, from India
The tariff classification of Isosorbide Dinitrate Tablets in dosage form, from India
The tariff classification of Clopidogrel Bisulfate Tablets in dosage form, from India
Follow N302362
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.